Marshall Wace, LLP Abb Vie Inc. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,677,268 shares of ABBV stock, worth $288 Million. This represents 0.48% of its overall portfolio holdings.

Number of Shares

1,677,268

Previous 106,000 1482.33%

Holding current value

$288 Million

Previous $16.4 Million 1759.43%

% of portfolio

0.48%

Previous 0.03%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$159.82 - $182.1 $239 Million - $272 Million	-1,495,772 Reduced 47.14%	1,677,268 $305 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $101 Million - $114 Million	-733,450 Reduced 18.78%	3,173,040 $492 Million
Q3 2023 Nov 14, 2023	BUY	$133.59 - $154.65 $401 Million - $465 Million	3,004,224 Added 332.96%	3,906,490 $582 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $16.1 Million - $20 Million	121,471 Added 15.56%	902,266 $122 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $110 Million - $127 Million	763,796 Added 4493.18%	780,795 $124 Million

Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $4.04 Million - $4.84 Million	-29,179 Reduced 63.19%	16,999 $2.75 Million
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $50.4 Million - $57.8 Million	-375,414 Reduced 89.05%	46,178 $6.2 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $107 Million - $136 Million	-778,337 Reduced 64.87%	421,592 $64.6 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $117 Million - $145 Million	886,248 Added 282.53%	1,199,929 $195 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $30.5 Million - $38.6 Million	284,278 Added 966.83%	313,681 $42.5 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $2.61 Million - $2.97 Million	24,568 Added 508.13%	29,403 $3.17 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $18 Million - $20.1 Million	-171,309 Reduced 97.26%	4,835 $545,000
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $10.8 Million - $11.9 Million	-105,571 Reduced 37.47%	176,144 $19.1 Million
Q4 2020 Feb 16, 2021	SELL	$80.49 - $108.67 $19 Million - $25.6 Million	-235,438 Reduced 45.53%	281,715 $30.2 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $66.3 Million - $77.9 Million	-772,167 Reduced 59.89%	517,153 $45.3 Million
Q2 2020 Aug 13, 2020	BUY	$73.37 - $98.18 $51.7 Million - $69.2 Million	704,319 Added 120.4%	1,289,320 $127 Million
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $32.2 Million - $48.9 Million	499,540 Added 584.52%	585,001 $44.6 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.82 Million - $2.27 Million	25,182 Added 41.78%	85,461 $7.57 Million
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $2.75 Million - $3.31 Million	-43,693 Reduced 42.02%	60,279 $4.56 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $4.89 Million - $6.26 Million	74,484 Added 252.59%	103,972 $7.56 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $17.8 Million - $20.9 Million	-230,525 Reduced 88.66%	29,488 $2.38 Million
Q4 2018 Feb 14, 2019	BUY	$77.85 - $96.01 $20.2 Million - $25 Million	260,013 New	260,013 $24 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Abb Vie Inc. Transaction History